**Core Concept**
Herpes simplex encephalitis (HSE) is a severe and potentially life-threatening infection of the brain caused by the herpes simplex virus (HSV). The treatment of choice for HSE involves antiviral medications that can selectively target and inhibit the replication of the virus.

**Why the Correct Answer is Right**
Acyclovir is a nucleoside analog that acts as a prodrug, requiring activation by viral thymidine kinase (TK) to its triphosphate form. This form then selectively inhibits viral DNA polymerase, preventing the replication of the HSV. Acyclovir's mechanism of action is highly specific to the viral enzyme, reducing the risk of toxicity to the host cells.

**Why Each Wrong Option is Incorrect**
**Option A:** 5-Hydroxy deoxyuridine (5-HU) is not a commonly used antiviral medication for HSE. It is actually a precursor to thymidine, which is involved in DNA synthesis, but it does not possess antiviral properties.

**Option C:** Gancyclovir is an antiviral medication used to treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients. While it has some activity against HSV, it is not the preferred treatment for HSE.

**Option D:** None of the above is incorrect because Acyclovir is indeed the drug of choice for HSE.

**Clinical Pearl / High-Yield Fact**
When treating HSE, it's essential to initiate antiviral therapy promptly, ideally within 24-48 hours of symptom onset, to improve outcomes. Acyclovir is typically administered intravenously in high doses for 14-21 days.

**✓ Correct Answer: B. Acyclovir**